Heard Hanoncock earlier explaining how the two different track and trace apps have both been in deveopment as is standard practice in business. He was lying - you could hear it in his voice. In the pharmaceutical industry, a company will have one lead compound and it will be this that goes into the eye-wateringly expensive clinical development phase. Nobody takes rival platforms in parallel into human testing. He is relying on the fact that some early work with the rival platform will have been done. His claim is a bit like West Yorkshire police saying they had a parallel investigation on Peter Sutcliffe when they were chasing 'Wearside Jack', based on the fact that Sutcliff's name came up at a meeting and was dismissed.
Last edited: